CytoDyn Announces Progress With DNA Pre-Vaccines For Influenza

NEW YORK--(BUSINESS WIRE)--CytoDyn, Inc. (OTCBB:CYDY) announced today that optimization of the Company’s DNA-based pre-vaccines for influenza (the flu) will be reported in an upcoming issue of the Journal of Virology on line ( The encouraging results of the optimization technique (known as “codone optimization”) are described in a paper by S. Xang, J. Taffe, C. Parker, A. Solórzano, Hiong Cao, Adolfo García-Sastre and Shan Lu, from The University of Massachusetts Medical School, Worcester, MA, and the Mount Sinai School of Medicine, New York, NY.

Back to news